Table 1 Basic characteristics of the study participants with and without gout

Age (yr)

44.2 (12.0)

44.0 (12.4)

48.0 (11.5)

9.105

<0.001

Male gender (%)

59.1

81.2

98.5

139.127^a

<0.001

Smoking (positive%)

22.9

30.2

42.5

48.886^a

<0.001

Drinking (positive%)

32.8

44.3

56.8

43.686^a

<0.001

H. pylori infection (positive%) (number)

26.3 (14,103)

27.2 (4108)

35.0 (252)

20.672^a

<0.001

BMI (kg/m²)

23.9 (3.3)

25.5 (3.2)

26.5 (3.4)

8.156

<0.001

WC (cm)

82.8 (10.6)

88.3 (9.3)

92.4 (8.6)

12.130

<0.001

SBP (mmHg)

121.9 (16.7)

125.8 (16.0)

130.0 (15.7)

6.690

<0.001

DBP (mmHg)

73.2 (11.2)

76.1 (11.1)

79.6 (11.0)

8.216

<0.001

FBG (mmol/L)

5.17 (4.87–5.70)

5.27 (4.95–5.68)

5.42 (5.05–5.94)

6.769^b

<0.001

HbA1c (%)

5.40 (5.20–5.70)

5.50 (5.20–5.80)

5.60 (5.33–6.60)

8.222^b

<0.001

TP (g/L)

72.4 (4.0)

73.1 (4.0)

73.0 (4.1)

0.405

0.686

ALT (U/L)

20.0 (14.0–30.0)

26.0 (18.0-40.5)

29.0 (24.0–39.0)

3.559^b

<0.001

AST (U/L)

21.0 (18.0–26.0)

24.0 (20.0–29.0)

25.0 (21.0–31.0)

4.389^b

<0.001

ALP (U/L)

71.7 (21.7)

75.1 (20.7)

75.3 (19.7)

0.259

0.795

GGT (U/L)

22.0 (15.0–38.0)

33.0 (22.0–54.0)

42.0 (26.0–65.0)

7.498^b

<0.001

TBil (µmol/L)

13.9 (11.0-17.8)

14.8 (11.8–18.6)

14.6 (11.6–18.6)

0.239^b

0.811

TG (mmol/L)

1.25 (0.87–1.87)

1.69 (1.17–2.43)

2.07 (1.49–2.88)

9.744^b

<0.001

TC (mmol/L)

5.08 (0.98)

5.25 (1.02)

5.28 (1.03)

0.783

0.434

LDL-C (mmol/L)

3.17 (0.79)

3.31 (0.81)

3.33 (0.82)

0.592

0.554

HDL-C (mmol/L)

1.31 (0.31)

1.20 (0.27)

1.16 (0.26)

3.873

<0.001

BUN (mmol/L)

5.02 (1.23)

5.26 (1.22)

5.33 (1.44)

1.416

0.157

CR (µmol/L)

72.2 (17.5)

80.3 (15.6)

89.7 (50.7)

4.951

<0.001

UA (µmol/L)

358.6 (92.0)

456.0 (429–540)

494.0 (417–561)

8.480^b

<0.001